Palvella Therapeutics, Inc. (PVLA)
85.66
+3.33
(+4.04%)
USD |
NASDAQ |
Feb 20, 16:00
85.57
-0.09
(-0.11%)
After-Hours: 20:00
Palvella Therapeutics EPS Diluted (Quarterly) : -1.025 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Ligand Pharmaceuticals, Inc. | 5.685 |
| Axsome Therapeutics, Inc. | -0.9442 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.34M |
| Total Expenses (Quarterly) | 11.34M |
| Enterprise Value | 966.37M |
| Earnings Yield | -7.66% |
| Normalized Earnings Yield | -7.326 |